Genome-Wide Analysis of Ets-Family Dna-Binding in Vitro and in Vivo
Gong-Hong Wei,Gwenael Badis,Michael F. Berger,Teemu Kivioja,Kimmo Palin,Martin Enge,Martin Bonke,Arttu Jolma,Markku Varjosalo,Andrew R. Gehrke,Jian Yan,Shaheynoor Talukder,Mikko Turunen,Mikko Taipale,Hendrik G. Stunnenberg,Esko Ukkonen,Timothy R. Hughes,Martha L. Bulyk,Jussi Taipale
DOI: https://doi.org/10.1038/emboj.2010.106
2010-01-01
Abstract:Members of the large ETS family of transcription factors (TFs) have highly similar DNA-binding domains (DBDs)-yet they have diverse functions and activities in physiology and oncogenesis. Some differences in DNA-binding preferences within this family have been described, but they have not been analysed systematically, and their contributions to targeting remain largely uncharacterized. We report here the DNA-binding profiles for all human and mouse ETS factors, which we generated using two different methods: a high-throughput microwell-based TF DNA-binding specificity assay, and protein-binding microarrays (PBMs). Both approaches reveal that the ETS-binding profiles cluster into four distinct classes, and that all ETS factors linked to cancer, ERG, ETV1, ETV4 and FLI1, fall into just one of these classes. We identify amino-acid residues that are critical for the differences in specificity between all the classes, and confirm the specificities in vivo using chromatin immunoprecipitation followed by sequencing (ChIP-seq) for a member of each class. The results indicate that even relatively small differences in in vitro binding specificity of a TF contribute to site selectivity in vivo.